SEARCH

SEARCH BY CITATION

References

  • Chillon M et al. (1995) Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med, 332, 14751480.
  • Chu CS et al. (1991) Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J, 10, 13551363.
  • Chu CS, Trapnell BC, Curristin S, Cutting GR and Crystal RG (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet, 3, 151156.
  • Cockrill BA and Hales CA (1999) Allergic bronchopulmonary aspergillosis. Annu Rev Med, 50, 303316.
  • Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM and Jowell PS (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med, 339, 653658.
  • Coolidge CJ, Seely RJ and Patton JG (1997) Functional analysis of the polypyrimidine tract in pre-mRNA splicing. Nucleic Acids Res, 25, 888896.
  • Cramer P, Caceres J, Cazalla D, Kadener S, Muro A, Baralle F and Kornblihtt A (1999) Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell, 4, 251258.
  • Cuppens H et al. (1998) Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest, 101, 487496.
  • Delaney SJ, Rich DP, Thomson SA, Hargrave MR, Lovelock PK, Welsh MJ and Wainwright BJ (1993) Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nature Genet, 4, 426431.
  • Dörk T et al. (1997) Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet, 100, 365377.
  • Ge H, Zuo P and Manley JL (1991) Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators. Cell, 66, 373382.
  • Gil A, Sharp PA, Jamison SF and Garcia-Blanco MA (1991) Characterization of cDNAs encoding the polypyrimidine tract-binding protein. Genes Dev, 5, 12241236.
  • Girodon E et al. (1997) CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet, 5, 149155.
  • Hanamura A, Caceres JF, Mayeda A, Franza BR,Jr and Krainer AR (1998) Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA, 4, 430444.
  • Irving RM, McMahon R, Clark R and Jones NS (1997) Cystic fibrosis transmembrane conductance regulator gene mutations in severe nasal polyposis. Clin Otolaryngol, 22, 519521.
  • Kazazian HH,Jr and Moran JV (1998) The impact of L1 retrotransposons on the human genome. Nature Genet, 19, 1924.
  • Kiesewetter S et al. (1993) A mutation in CFTR produces different phenotypes depending on chromosomal background. Nature Genet, 5, 274277.
  • Larriba S, Bassas L, Gimenez J, Ramos MD, Segura A, Nunes V, Estivill X and Casals T (1998) Testicular CFTR splice variants in patients with congenital absence of the vas deferens. Hum Mol Genet, 7, 17391743.
  • Mak V, Jarvi KA, Zielenski J, Durie P and Tsui LC (1997) Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens. Hum Mol Genet, 6, 20992107.
  • Mulligan GJ, Guo W, Wormsley S and Helfman DM (1992) Polypyrimidine tract binding protein interacts with sequences involved in alternative splicing of β-tropomyosin pre-mRNA. J Biol Chem, 267, 2548025487.
  • Muro AF, Caputi M, Pariyarath R, Pagani F, Buratti E and Baralle FE (1999) Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol Cell Biol, 19, 26572671.
  • Neitzel H (1986) A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet, 73, 320326.
  • Niksic M, Romano M, Buratti E, Pagani F and Baralle FE (1999) Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum Mol Genet, 8, 23392349.
  • Nissim-Rafinia M, Chiba-Falek O, Sharon G, Boss A and Kerem B (2000) Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations. Hum Mol Genet, 9, 17711778.
  • Ou SH, Wu F, Harrich D, Garcia-Martinez LF and Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol, 69, 35843596.
  • Pagani F, Buratti E, Stuani C, Romano M, Zuccato E, Niksic M, Giglio L, Faraguna D and Baralle FE (2000) Splicing factors induce CFTR exon 9 skipping through a non-evolutionary conserved intronic element. J Biol Chem, 275, 2104121047.
  • Pignatti PF, Bombieri C, Marigo C, Benetazzo M and Luisetti M (1995) Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet, 4, 635639.
  • Ramchatesingh J, Zahler AM, Neugebauer KM, Roth MB and Cooper TA (1995) A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol Cell Biol, 15, 48984907.
  • Rave-Harel N et al. (1997) The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet, 60, 8794.
  • Rozmahel R, Heng HH, Duncan AM, Shi XM, Rommens JM and Tsui LC (1997) Amplification of CFTR exon 9 sequences to multiple locations in the human genome. Genomics, 45, 554561.
  • Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M and Braganza J (1998) Mutations of the cystic fibrosis gene in patients with idiopathic pancreatitis. N Engl J Med, 339, 645652.
  • Shelley CS and Baralle FE (1987) Deletion analysis of a unique 3′ splice site indicates that alternating guanine and thymine residues represent an efficient splicing signal. Nucleic Acids Res, 15, 37873799.
  • Singh R, Valcarcel J and Green MR (1995) Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science, 268, 11731176.
  • Strong TV et al. (1993) Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance. Hum Mol Genet, 2, 225230.
  • Teng H, Jorissen M, Van Poppel H, Legius E, Cassiman JJ and Cuppens H (1997) Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum Mol Genet, 6, 8590.
  • Tu GC, Cao QN, Zhou F and Israel Y (1998) Tetranucleotide GGGA motif in primary RNA transcripts. Novel target site for antisense design. J Biol Chem, 273, 2512525131.
  • Valcarcel J, Gaur RK, Singh R and Green MR (1996) Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of basepairing with U2 snRNA. Science, 273, 17061709.
  • Welsh MJ, Tsui L-C, Boat TF and Beaudet AL (1995) Cystic fibrosis. In Scriver,C.R., Beaudet,A.L., Sly,W.S. and Valle,D. (eds), The Metabolic and Molecular Bases of Inherited Diseases. 7th edn. McGraw-Hill, New York, NY, pp. 37863799.